Learn how to analyze recent clinical data of current and emerging targeted therapies and potential biomarkers for severe asthma with expert faculty Michael Wechsler, MD, MMSc. Get practical tools to integrate into your practice for personalized treatment of your severe asthma patients. This module incorporates video-recorded patient cases to apply learning, increase interactivity, and provide an innovative format.

This activity is accredited for .5 AMA PRA Category 1 Credits™.  It will take approximately 30 minutes to complete the module including the pre/post-test and evaluation.  You will receive rationale for the post-test questions as a learning tool.

 

Register for this Course
National Jewish Health
1400 Jackson Street
Denver, CO 80206
© 2017 National Jewish Health


Grant Statement
This educational activity is supported by educational grants from AstraZeneca Pharmaceuticals LP, GlaxoSmithKline, and Sanofi Genzyme and Regeneron Pharmaceuticals.